{
    "organizations": [],
    "uuid": "361a1449673fe10747be64d025ca61dc50cb0ae2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dar-bioscience-begins-trial-for-co/brief-dar-bioscience-begins-trial-for-contraceptive-candidate-ovaprene-idUSFWN1SM105",
    "ord_in_thread": 0,
    "title": "BRIEF-Daré Bioscience Begins Trial For Contraceptive Candidate Ovaprene",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Dare Bioscience Inc:\n* DARÉ BIOSCIENCE, INC. ANNOUNCES TRIAL INITIATION FOR OVAPRENE® NON-HORMONAL MONTHLY CONTRACEPTIVE CANDIDATE\n* DARE BIOSCIENCE INC - DATA FROM OVAPRENE STUDY IS EXPECTED TO BE AVAILABLE IN SECOND HALF OF 2019 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T20:09:00.000+03:00",
    "crawled": "2018-05-16T19:13:33.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "dare",
        "bioscience",
        "inc",
        "daré",
        "bioscience",
        "announces",
        "trial",
        "initiation",
        "monthly",
        "contraceptive",
        "candidate",
        "dare",
        "bioscience",
        "inc",
        "data",
        "ovaprene",
        "study",
        "expected",
        "available",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}